|
Delayed
NSE India S.E.
11:01:21 14/05/2026 BST
|
5-day change
|
1st Jan Change
|
|
22,613.10 PTS
|
+1.05%
|
|
-2.59%
|
-5.27%
|
| 11:43am |
CLSA Upgrades Oil India to Accumulate from Reduce; Price Target is INR570
|
MT
| | 11:43am |
Avendus Spark Upgrades Cipla to Add from Reduce; Price Target is INR1,455
|
MT
| | 11:43am |
Nirmal Bang Downgrades Cipla to Hold from Buy; Price Target is INR1,404
|
MT
| | 11:41am |
ICICI Securities Downgrades Hindustan Petroleum to Add from Buy; Price Target is INR430
|
MT
| | 11:37am |
Dilip Buildcon March-quarter consol net profit 620.5 million rupees
|
RE
| | 11:37am |
FUNDVIEW-India's ICICI Pru Life temporarily ups long-bond exposure, sees rate hikes after September
|
RE
| | 10:57am |
Hudco March-quarter consol profit 19.81 billion rupees
|
RE
| | 09:33am |
Jefferies Adjusts Hindustan Petroleum's Price Target to INR275 from INR305, Keeps at Underperform
|
MT
| | 09:31am |
Jefferies Adjusts Crompton Greaves Consumer Electricals' Price Target to INR330 From INR290, Keeps at Buy
|
MT
| | 09:29am |
India's Hindustan Aeronautics posts quarterly profit rise as 'other income' surges
|
RE
| | 09:23am |
Nomura Downgrades Hindustan Petroleum to Neutral From Buy, Adjusts Price Target to INR440 From INR550
|
MT
| | 09:21am |
Hindustan Aeronautics Posts Higher Consolidated Profit in Fiscal Q4
|
MT
| | 09:21am |
Nomura Adjusts Crompton Greaves Consumer Electricals' Price Target to INR335 From INR318, Keeps at Buy
|
MT
| | 08:55am |
India's BSE to conduct mock trading on May 16 for currency, commodity, equity derivatives and equity segment
|
RE
| | 08:44am |
Alembic Pharmaceuticals Gets US FDA's Establishment Inspection Report for Karakhadi, India Unit
|
MT
| | 08:14am |
Hindustan Aeronautics Q4 consol net profit 41.96 bln rupees
|
RE
| | 07:51am |
Crompton Greaves Moves Upmarket with Launch of Crompton Rhion Brand
|
MT
| | 07:36am |
Mahindra and Mahindra says unit sells remaining 3.58% stake in CIE Automotive S.A for EUR 126 million
|
RE
| | 07:34am |
HFCL approves establishment of defence manufacturing facility in Andhra Pradesh
|
RE
| | 07:33am |
Alembic Pharmaceuticals receives USFDA establishment inspection report (EIR) for its injectable facility
|
RE
| | 07:25am |
HFCL Plans New Manufacturing Unit in Andhra Pradesh, India; Shares Down 4%
|
MT
| | 07:01am |
Jefferies Adjusts Torrent Power's Price Target to INR1,700 from INR1,485, Keeps at Buy
|
MT
| | 06:51am |
Jefferies Adjusts IIFL Finance's Price Target to INR520 from INR500, Keeps at Hold
|
MT
| | 06:40am |
Indoco Remedies says Malta Medicines Authority inspected Indoco Remedies' Baddi unit from Jan 29-Feb 3, 2026
|
RE
| | 06:34am |
Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Darolutamide Tablets
|
MT
| | 05:41am |
Alembic Pharmaceuticals receives USFDA tentative approval for darolutamide tablets, 300 mg
|
RE
| | 03:42am |
Power Finance Corporation's Consolidated Profit Grows in Fiscal Q4
|
MT
| |
05-13 |
W.Africa Crude-Angolan cargoes overhang ahead of July programme
|
RE
| |
05-13 |
Care Ratings March-quarter consol net profit 528.3 million rupees
|
RE
| |
05-13 |
Zydus Lifesciences to buy Assertio for $166.4 million
|
RE
| |
05-13 |
Oil India recommends final dividend of 1 rupee per share for FY2025-26
|
RE
| |
05-13 |
Metropolis Health declares 2nd interim dividend of 1 rupee per share
|
RE
| |
05-13 |
EClerx Services recommends final dividend of 1 rupee per share
|
RE
| |
05-13 |
Oil India March-quarter profit 17.9 billion rupees
|
RE
| |
05-13 |
Teamlease Services files writ petition with High Court of Karnataka
|
RE
| |
05-13 |
Dcm Shriram March-quarter Consol Net Pat 3.7 Billion Rupees
|
RE
| |
05-13 |
DCM Shriram says approved capital expenditure plan of unit Hindusthan Specialty Chemicals
|
RE
| |
05-13 |
Metropolis Health March-quarter consol net profit 509 million rupees
|
RE
| |
05-13 |
IIFL Finance says repurchased, settled $12.6 million out of $425 million senior secured fixed rate notes due 2028
|
RE
| |
05-13 |
Dlf recommends dividend of 8 rupees per share for FY 2025-26
|
RE
|
No results for this search
Highest NIFTY 500 increases
|
|
|
|
+13.88%
|
|
|
+9.88%
|
|
|
+8.60%
|
|
|
+8.22%
|
|
|
+7.93%
|
The sharpest declines in NIFTY 500.
|
|
|
|
-5.85%
|
|
|
-6.39%
|
|
|
-7.13%
|
|
|
-7.52%
|
|
|
-9.36%
|
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|